Improving the use of genomic medicine in clinical practice
Official title: The IGNITE II CC: Engagement, Coordination, Demonstration, and Dissemination
Funded at Duke University · NIH-10827791 · Data updated 2026-11-12
This study is working to make genomic medicine easier to use in hospitals, so patients can get better access to personalized treatments based on their genetic information.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project start | May 1, 2023 |
| Project end | June 30, 2025 |
| Funding year | 2023 |
| Award (this year) | $3,510,908 |
| NIH project number | 3U01HG010225-05S3 |
| Project ID | NIH-10827791 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation include individuals interested in genomic medicine and those who may benefit from personalized treatment approaches.
✕Less likely to help
Patients who are not interested in genomic medicine or do not have conditions that could be addressed through genomic approaches may not receive benefit from this research.
What this research studies
This research focuses on enhancing the implementation of genomic medicine by addressing key challenges such as the lack of information technology infrastructure and data standards. The IGNITE II Coordination Center will work to recruit participants and develop best practices for pragmatic clinical trials. By creating a platform for data management and analysis, the project aims to streamline the integration of genomic data into clinical settings. Patients may benefit from improved access to genomic medicine and more personalized treatment options as a result of this initiative.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized healthcare through the integration of genomic medicine into clinical practice.
How similar studies have gone: Previous initiatives in genomic medicine have shown promise in improving patient outcomes, indicating that this approach has potential for success.
Where this research is happening
-
Duke University
Durham, United States Active
Researchers
- Principal investigator: Wyatt, Christina M — Duke University
- Study coordinator: Wyatt, Christina M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.